Emily Finnegan

Company: GSK

Job title: Director, Global Regulatory Affairs, Precision Medicine Digital Health

Seminars:

Panel Discussion: Balancing Innovation & Compliance in Diagnostic Testing Amidst the Final LDT Rule to Ensure Patient Access to Great Drugs 9:30 am

Debating the positive and negative aspects of the Final LDT Rule for liquid biopsy innovation Understanding the responsibilities for drug-diagnostic partnerships in ensuring swift approvals How can we minimize financial and temporal burdens of complex approvals in the US?Read more

day: Day Two AM